Board approves variation in IPO proceeds usage of Rs 1000.16 mn

Results View source PDF Explain this filing

SENORES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.5%Reaction day

₹1326.90

prior close

₹1329.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.0%-0.5% vs market

Pharmaceuticals peers, median of 165sector+0.8%-0.3% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 0.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

-0.2

15m

+0.4

30m

-0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.5+1.0-0.5+0.8-0.3

Next day

-1.3+1.2-2.5+0.3-1.6

+0.6+2.1-1.4+0.9-0.2

+4.7+1.7+2.9+1.2+3.5

+1.9+1.9-0.0+0.6+1.3

+2.8+1.2+1.5+0.1+2.6

+6.9+1.1+5.8+0.6+6.3

15d

+6.0+1.6+4.3+1.7+4.2

-2.7+0.1-2.8-0.3-2.5

+8.9+6.6+2.2+2.7+6.2

+4.5+5.5-0.9+3.2+1.3

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Senores Pharmaceuticals board approved reallocating about Rs 1000.16 million (around Rs 100 crore) of unutilised IPO proceeds out of the total Rs 5000 million (Rs 500 crore) raised at the time of its IPO. The change in use of these funds is subject to shareholder approval through a postal ballot. The board meeting was held on June 29, 2026, from 4:15 PM to 5:00 PM.

Likely market impact

Investors will get to vote via postal ballot on changing the planned use of IPO money; outcome may affect growth plans funded by these proceeds.